8-K: 60 Degrees Pharma Corrects Affiliate Share Count
Correction Filing
60 Degrees Pharmaceuticals, Inc. filed an 8-K to correct an error in the reported beneficial ownership of an affiliate's common stock.
Summary
- An error was identified in the calculation of common stock shares beneficially owned by an affiliate of the Company.
- The incorrect number of shares previously reported in the Prospectus Supplement dated March 13, 2026, was 21,490 shares.
- The correct number of shares beneficially owned by the affiliate is 23,367 shares.
- This error originated from an incorrect total share amount reported in a Form 4 filed on September 15, 2025, which was subsequently carried forward into a Form 4 filed on December 16, 2025, and ultimately into the Prospectus Supplement.
- After giving effect to a 1-for-4 reverse stock split, the corrected total number of shares beneficially owned by the affiliate is 16,781 shares, rather than the previously reported 15,905 shares.
- No other information in the Prospectus Supplement is affected by this correction.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as the company is transparently correcting a factual error, which enhances data integrity for investors.
Future Outlook
NA
Management Comments
- The Company determined that an error was made in the calculation of the number of shares of common stock beneficially owned by an affiliate of the Company.
Industry Context
StockSavvy.ai notes that such corrections, while not uncommon, underscore the importance of meticulous data accuracy in regulatory filings, particularly concerning beneficial ownership which can impact perceptions of control and insider holdings.
Stakeholder Impact
- Shareholders: Improved accuracy of beneficial ownership data, providing a clearer picture of affiliate holdings.
- Regulatory Authorities: Demonstrates compliance with SEC disclosure requirements by correcting previously filed information.
Key Dates
| Date | Description |
|---|---|
| 2025-09-15 | Date of initial Form 4 filing containing an incorrect total share amount. |
| 2025-12-16 | Date of subsequent Form 4 filing that carried forward the error. |
| 2026-03-13 | Date of Prospectus Supplement containing the incorrect beneficial ownership disclosure. |
| 2026-03-20 | Date of report and determination of error; filing of Form 8-K to correct disclosure. |
Keywords
60 Degrees Pharmaceuticals, SXTP, Form 8-K, beneficial ownership, share count correction, affiliate shares, prospectus supplement, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.